Tali Ball, PhD is the Director of the Stanford Translational Anxiety Research (STAR) Lab and an Instructor in the Stanford Department of Psychiatry and Behavioral Sciences. Her primary research aim is to translate neurobiologically-based models of anxiety into improved treatment outcomes. She received her PhD in Clinical Psychology from the SDSU/UCSD Joint Doctoral Program, where her dissertation work established relationships between brain activation during fear extinction learning and anxiety reduction following a brief exposure intervention. Her postdoctoral research focused on developing clinically useful metrics of brain circuit function and incorporating neuroscience-based assessments into clinical practice. Her work brings together clinical psychology, neuroscience, and computational approaches, always with an eye towards how the results of the science can be directly implemented in clinical practice.

Clinical Focus

  • Psychology

Academic Appointments

  • Instructor, Psychiatry and Behavioral Sciences

Professional Education

  • Fellowship: Stanford University Psychology Postdoctoral Fellowship (2018) CA
  • Internship: VA San Diego Health System/University of CA San Diego Psychology Internship Program (2015) CA
  • PhD Training: UC San Diego Office of the Registrar (2015) CA

Clinical Trials

  • Evaluating a Personalized Trans-Diagnostic Group Therapy for Anxiety Not Recruiting

    This study is examining the impact of a therapy group for all anxiety disorders provided by the Stanford Department of Psychiatry and Behavioral Sciences's Psychosocial Treatment Clinic on anxiety symptoms, impairment, and access to quality mental health care.

    Stanford is currently not accepting patients for this trial.

    View full details

  • Social Anxiety Telehealth Therapy Study Not Recruiting

    The COVID-19 pandemic has substantially increased the risk of adverse mental health outcomes; while physical distancing is required to reduce infection risk, it also increases loneliness and isolation and prevents access to traditional in-person therapy, which further contribute to risk of adverse mental health outcomes. These problems may be especially acute for individuals with social anxiety disorder (as many as 12% of Americans), however there is a limited evidence-base for telehealth options to directly address social anxiety. This project aims to adapt exposure therapy for social anxiety to a telehealth and physical distancing-compatible intervention, and test whether this effectively decreases loneliness in adults with elevated social anxiety.

    Stanford is currently not accepting patients for this trial. For more information, please contact Tali Ball, PhD, 650-723-2686.

    View full details

  • Using the Neuroscience of Fear Extinction for Anxiety Reduction Not Recruiting

    Social anxiety disorder affects as many as 12% of Americans, resulting in significant distress and disability. Although exposure therapy is one of the best treatments available, as many as 25% of patients do not respond and we do not know why. Extinction learning is thought to be the mechanism of exposure therapy, and the neuroscience of extinction learning has advanced significantly since exposure therapy was developed; however, there has been little application towards improved clinical outcomes. This project aims to improve exposure therapy response for patients with social anxiety disorder by directly linking exposure therapy response to the neurobiology of extinction learning. It also aims to increase our scientific understanding of how brain circuits work to support extinction learning. To do this, 80 adults with social anxiety disorder will randomly be assigned to either receive exposure therapy right away, or to wait before therapy. Participants will all complete a functional magnetic resonance imaging scan to assess extinction learning before the therapy.

    Stanford is currently not accepting patients for this trial. For more information, please contact Tali M Ball, PhD, 650-723-2686.

    View full details

2020-21 Courses

All Publications

  • Quantifying person-level brain network functioning to facilitate clinical translation TRANSLATIONAL PSYCHIATRY Ball, T. M., Goldstein-Piekarski, A. N., Gatt, J. M., Williams, L. M. 2017; 7: e1248


    Although advances in neuroimaging have yielded insights into the intrinsic organization of human brain networks and their relevance to psychiatric and neurological disorders, there has been no translation of these insights into clinical practice. One necessary step toward clinical translation is identifying a summary metric of network function that is reproducible, reliable, and has known normative data, analogous to normed neuropsychological tests. Our aim was therefore to establish the proof of principle for such a metric, focusing on the default mode network (DMN). We compared three candidate summary metrics: global clustering coefficient, characteristic path length, and average connectivity. Across three samples totaling 322 healthy, mostly Caucasian adults, average connectivity performed best, with good internal consistency (Cronbach's α=0.69-0.70) and adequate eight-week test-retest reliability (intra-class coefficient=0.62 in a subsample N=65). We therefore present normative data for average connectivity of the DMN and its sub-networks. These proof of principle results are an important first step for the translation of neuroimaging to clinical practice. Ultimately, a normed summary metric will allow a single patient's DMN function to be quantified and interpreted relative to normative peers.

    View details for PubMedID 29039851

  • Brain activation during fear extinction predicts exposure success DEPRESSION AND ANXIETY Ball, T. M., Knapp, S. E., Paulus, M. P., Stein, M. B. 2017; 34 (3): 257-266


    Exposure therapy, a gold-standard treatment for anxiety disorders, is assumed to work via extinction learning, but this has never been tested. Anxious individuals demonstrate extinction learning deficits, likely related to less ventromedial prefrontal cortex (vmPFC) and more amygdala activation, but the relationship between these deficits and exposure outcome is unknown. We tested whether anxious individuals who demonstrate better extinction learning report greater anxiety reduction following brief exposure.Twenty-four adults with public speaking anxiety completed (1) functional magnetic resonance imaging during a conditioning paradigm, (2) a speech exposure session, and (3) anxiety questionnaires before and two weeks postexposure. Extinction learning was assessed by comparing ratings to a conditioned stimulus (neutral image) that was previously paired with an aversive noise against a stimulus that had never been paired. Robust regression analyses examined whether brain activation during extinction learning predicted anxiety reduction two weeks postexposure.On average, the conditioning paradigm resulted in acquisition and extinction effects on stimulus ratings, and the exposure session resulted in reduced anxiety two weeks post-exposure. Consistent with our hypothesis, individuals with better extinction learning (less negative stimulus ratings), greater activation in vmPFC, and less activation in amygdala, insula, and periaqueductal gray reported greater anxiety reduction two weeks postexposure.To our knowledge, this is the first time that the theoretical link between extinction learning and exposure outcome has been demonstrated. Future work should examine whether extinction learning can be used as a prognostic test to determine who is most likely to benefit from exposure therapy.

    View details for DOI 10.1002/da.22583

    View details for PubMedID 27921340

  • Intrinsic reward circuit connectivity profiles underlying symptom and quality of life outcomes following antidepressant medication: a report from the iSPOT-D trial. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology Fischer, A. S., Holt-Gosselin, B., Fleming, S. L., Hack, L. M., Ball, T. M., Schatzberg, A. F., Williams, L. M. 2020


    There is a critical need to better understand the neural basis of antidepressant medication (ADM) response with respect to both symptom alleviation and quality of life (QoL) in major depressive disorder (MDD). Reward neurocircuitry has been implicated in QoL, the neural basis of MDD, and the mechanisms of ADM response. Yet, we do not know whether change in reward neurocircuitry as a function of ADM is associated with change in symptoms and QoL. To address this gap in knowledge, we analyzed data from 128 patients with MDD who participated in the iSPOT-D trial and were assessed with functional neuroimaging pre- and post-ADM treatment (randomized to sertraline, venlafaxine-XR, or escitalopram). 58 matched healthy controls were scanned at the same time points. We quantified functional connectivity (FC) of reward neurocircuitry using nucleus accumbens (NAc) seed regions of interest, and then characterized how changes in FC relate to symptom response (primary outcome) and QoL response (secondary outcome). Symptom responders showed an increase in NAc-dorsal anterior cingulate cortex (ACC) FC relative to non-responders (p<0.001) which was associated with improvement in physical QoL (p<0.0003), and a decrease in NAc-inferior parietal lobule FC relative to controls (p<0.001). QoL response was characterized by increases in FC between NAc-ventral ACC for environmental, NAc-thalamus for physical, and NAc-paracingulate gyrus for social domains (p<0.001). Symptom responders to sertraline were distinguished by a decrease in NAc-insula FC (p<0.001) and to venlafaxine-XR by an increase in NAc-inferior temporal gyrus FC (p<0.005). Findings suggest that change in reward neurocircuitry may underlie differential ADM response profiles with respect to symptoms and QoL in depression.

    View details for DOI 10.1038/s41386-020-00905-3

    View details for PubMedID 33230268

  • Double Dipping in Machine Learning: Problems and Solutions. Biological psychiatry. Cognitive neuroscience and neuroimaging Ball, T. M., Squeglia, L. M., Tapert, S. F., Paulus, M. P. 2019

    View details for DOI 10.1016/j.bpsc.2019.09.003

    View details for PubMedID 31678119

  • Attention Impairments and the "Inattention Biotype" in Major Depressive Disorder Keller, A., Ball, T., Williams, L. ELSEVIER SCIENCE INC. 2019: S244
  • Using Machine Learning to Characterize Circuit-Based Subtypes in Mood and Anxiety Disorders Young, C., Harati, S., Ball, T., Williams, L. ELSEVIER SCIENCE INC. 2019: S310
  • Using neuroimaging to predict relapse in stimulant dependence: A comparison of linear and machine learning models. NeuroImage. Clinical Gowin, J. L., Ernst, M., Ball, T., May, A. C., Sloan, M. E., Tapert, S. F., Paulus, M. P. 2019; 21: 101676


    OBJECTIVE: Relapse rates are consistently high for stimulant user disorders. In order to obtain prognostic information about individuals in treatment, machine learning models have been applied to neuroimaging and clinical data. Yet few efforts have been made to test these models in independent samples or show that they can outperform linear models. In this exploratory study, we examine whether machine learning models relative to linear models provide greater predictive accuracy and less overfitting.METHOD: This longitudinal study included 63 methamphetamine-dependent (training sample) and 29 cocaine-dependent (test sample) individuals who completed an MRI scan during residential treatment. Linear and machine learning models predicting relapse at a one-year follow up that were previously developed in the methamphetamine-dependent sample using neuroimaging and clinical variables were applied to the cocaine-dependent sample. Receiver operating characteristic analysis was used to assess performance using area under the curve (AUC) as the primary outcome.RESULTS: Twelve individuals in the cocaine-dependent sample remained abstinent, and 17 relapsed. The linear models produced more accurate prediction in the training sample than the machine learning models but showed reduced performance in the testing sample, with AUC decreasing by 0.18. The machine learning models produced similar predictive performance in the training and test samples, with AUC changing by 0.03. In the test sample, neither the linear nor the machine learning model predicted relapse at rates above chance.CONCLUSIONS: Although machine learning algorithms may have advantages, in this study neither model's performance was sufficient to be clinically useful. In order to improve predictive models, stronger predictor variables and larger samples are needed.

    View details for PubMedID 30665102

  • Precision Psychiatry AMERICAN PSYCHIATRIC ASSOCIATION PUBLISHING TEXTBOOK OF PSYCHIATRY, 7TH EDITION Williams, L. M., Ball, T. M., Kircos, C. L., Roberts, L. W. 2019: 771–90
  • Deep phenotyping of attention impairments and the 'Inattention Biotype' in Major Depressive Disorder. Psychological medicine Keller, A. S., Ball, T. M., Williams, L. M. 2019: 1–10


    Attention impairment is an under-investigated feature and diagnostic criterion of Major Depressive Disorder (MDD) that is associated with poorer outcomes. Despite increasing knowledge regarding mechanisms of attention in healthy adults, we lack a detailed characterization of attention impairments and their neural signatures in MDD.Here, we focus on selective attention and advance a deep multi-modal characterization of these impairments in MDD, using data acquired from n = 1008 patients and n = 336 age- and sex-matched healthy controls. Selective attention impairments were operationalized and anchored in a behavioral performance measure, assessed within a battery of cognitive tests. We sought to establish the accompanying neural signature using independent measures of functional magnetic resonance imaging (15% of the sample) and electroencephalographic recordings of oscillatory neural activity.Greater impairment on the behavioral measure of selective attention was associated with intrinsic hypo-connectivity of the fronto-parietal attention network. Not only was this relationship specific to the fronto-parietal network unlike other large-scale networks; this hypo-connectivity was also specific to selective attention performance unlike other measures of cognition. Selective attention impairment was also associated with lower posterior alpha (8-13 Hz) power at rest and was related to more severe negative bias (frequent misidentifications of neutral faces as sad and lingering attention on sad faces), relevant to clinical features of negative attributions and brooding. Selective attention impairments were independent of overall depression severity and of worrying or sleep problems.These results provide a foundation for the clinical translational development of objective markers and targeted therapeutics for attention impairment in MDD.

    View details for DOI 10.1017/S0033291719002290

    View details for PubMedID 31477195

  • Developing a Standardized Taxonomy of Circuit Dysfunction Related to Phenotypes of Mood and Anxiety Disorder Samara, Z., Ball, T., Goldstein-Piekarski, A., Grisanzio, K., Correa, C., Williams, L. M. ELSEVIER SCIENCE INC. 2018: S377
  • Intrinsic functional connectivity predicts remission on antidepressants: a randomized controlled trial to identify clinically applicable imaging biomarkers TRANSLATIONAL PSYCHIATRY Goldstein-Piekarski, A. N., Staveland, B. R., Ball, T. M., Yesavage, J., Korgaonkar, M. S., Williams, L. M. 2018; 8: 57


    Default mode network (DMN) dysfunction (particularly within the anterior cingulate cortex (ACC) and medial prefrontal cortex (mPFC)) has been implicated in major depressive disorder (MDD); however, its contribution to treatment outcome has not been clearly established. Here we tested the role of DMN functional connectivity as a general and differential biomarker for predicting treatment outcomes in a large, unmedicated adult sample with MDD. Seventy-five MDD outpatients completed fMRI scans before and 8 weeks after randomization to escitalopram, sertraline, or venlafaxine-XR. A whole-brain voxel-wise t-test identified profiles of pretreatment intrinsic functional connectivity that distinguished patients who were subsequently classified as remitters or non-remitters at follow-up. Connectivity was seeded in the PCC, an important node of the DMN. We further characterized differences between remitters, non-remitters, and 31 healthy controls and characterized changes pretreatment to posttreatment. Remitters were distinguished from non-remitters by relatively intact connectivity between the PCC and ACC/mPFC, not distinguishable from healthy controls, while non-remitters showed relative hypo-connectivity. In validation analyses, we demonstrate that PCC-ACC/mPFC connectivity predicts remission status with >80% cross-validated accuracy. In analyses testing whether intrinsic connectivity differentially relates to outcomes for a specific type of antidepressant, interaction models did not survive the corrected threshold. Our findings demonstrate that the overall capacity to remit on commonly used antidepressants may depend on intact organization of intrinsic functional connectivity between PCC and ACC/mPFC prior to treatment. The findings highlight the potential utility of functional scans for advancing a more precise approach to tailoring antidepressant treatment choices.

    View details for PubMedID 29507282

  • An Approach to Profiling Mood and Anxiety Disorders Based on Functional Brain Circuits, Behavior and Symptoms Samara, Z., Ball, T., Goldstein-Piekarshi, A. N., Grizansio, K. A., Correa, C., Williams, L. M. NATURE PUBLISHING GROUP. 2017: S368
  • Computational Psychiatry: New Perspectives on Mental Illness (Book Review) AMERICAN JOURNAL OF PSYCHIATRY Book Review Authored by: Ball, T. M., Goldstein-Piekarski, A. N. 2017; 174 (7): 698-+
  • Individualized relapse prediction: Personality measures and striatal and insular activity during reward-processing robustly predict relapse (vol 152, pg 93, 2015) DRUG AND ALCOHOL DEPENDENCE Gowin, J. L., Ball, T. M., Wittmann, M., Tapert, S. F., Paulus, M. P. 2017; 175: 255

    View details for PubMedID 28431752

    View details for PubMedCentralID PMC5501271

  • Clustering by Salience Network Activation to Emotional Faces Identifies a Transdiagnostic Subtype that is Associated with Specific Interoceptive Related Symptoms Goldstein-Piekarski, A., Ball, T., Samara, Z., Yesavage, J., Schatzberg, A., Korgaonkar, M., Williams, L. ELSEVIER SCIENCE INC. 2017: S133–S134
  • Neural Predictors of Initiating Alcohol Use During Adolescence AMERICAN JOURNAL OF PSYCHIATRY Squeglia, L. M., Ball, T. M., Jacobus, J., Brumback, T., Mckenna, B. S., Nguyen-Louie, T. T., Sorg, S. F., Paulus, M. P., Tapert, S. F. 2017; 174 (2): 172-185


    Underage drinking is widely recognized as a leading public health and social problem for adolescents in the United States. Being able to identify at-risk children before they initiate heavy alcohol use could have immense clinical and public health implications; however, few investigations have explored individual-level precursors of adolescent substance use. This prospective investigation used machine learning with demographic, neurocognitive, and neuroimaging data in substance-naive adolescents to predict alcohol use initiation by age 18.Participants (N=137) were healthy substance-naive adolescents (ages 12-14) who underwent neuropsychological testing and structural and functional magnetic resonance imaging (sMRI and fMRI), and then were followed annually. By age 18, 70 youths (51%) initiated moderate to heavy alcohol use, and 67 remained nonusers. Random forest classification models generated individual alcohol use outcome predictions based on demographic, neuropsychological, sMRI, and fMRI data.The final random forest model was 74% accurate, with good sensitivity (74%) and specificity (73%). The model contained 34 predictors contributing to alcohol use by age 18, including several demographic and behavioral factors (being male, higher socioeconomic status, early dating, more externalizing behaviors, positive alcohol expectancies), worse executive functioning, and thinner cortices and less brain activation in diffusely distributed regions of the brain. Inclusion of neuropsychological, sMRI, and fMRI data significantly increased the prediction accuracy of the model.The results provide evidence that multimodal neuroimaging data, as well as neuropsychological testing, can be used to generate predictions of future behaviors such as adolescent alcohol use with significantly better accuracy than demographic information alone.

    View details for DOI 10.1176/appi.ajp.2016.15121587

    View details for Web of Science ID 000396662200015

  • Functional Connectivity in the Default Mode Network: Establishing Reproducibility and Individual Norms Ball, T., Goldstein-Piekarski, A. N., Gatt, J., Fornito, A., Williams, L. M. NATURE PUBLISHING GROUP. 2016: S299–S300
  • Individualized relapse prediction: Personality measures and striatal and insular activity during reward-processing robustly predict relapse DRUG AND ALCOHOL DEPENDENCE Gowin, J. L., Ball, T. M., Wittmann, M., Tapert, S. F., Paulus, M. P. 2015; 152: 93–101


    Nearly half of individuals with substance use disorders relapse in the year after treatment. A diagnostic tool to help clinicians make decisions regarding treatment does not exist for psychiatric conditions. Identifying individuals with high risk for relapse to substance use following abstinence has profound clinical consequences. This study aimed to develop neuroimaging as a robust tool to predict relapse.68 methamphetamine-dependent adults (15 female) were recruited from 28-day inpatient treatment. During treatment, participants completed a functional MRI scan that examined brain activation during reward processing. Patients were followed 1 year later to assess abstinence. We examined brain activation during reward processing between relapsing and abstaining individuals and employed three random forest prediction models (clinical and personality measures, neuroimaging measures, a combined model) to generate predictions for each participant regarding their relapse likelihood.18 individuals relapsed. There were significant group by reward-size interactions for neural activation in the left insula and right striatum for rewards. Abstaining individuals showed increased activation for large, risky relative to small, safe rewards, whereas relapsing individuals failed to show differential activation between reward types. All three random forest models yielded good test characteristics such that a positive test for relapse yielded a likelihood ratio 2.63, whereas a negative test had a likelihood ratio of 0.48.These findings suggest that neuroimaging can be developed in combination with other measures as an instrument to predict relapse, advancing tools providers can use to make decisions about individualized treatment of substance use disorders.

    View details for PubMedID 25977206

    View details for PubMedCentralID PMC4458160



    Functional neuroimaging has led to significant gains in understanding the biological bases of anxiety and depressive disorders. However, the ability of functional neuroimaging to directly impact clinical practice is unclear. One important method by which neuroimaging could impact clinical care is to generate single patient level predictions that can guide clinical decision-making. The present review summarizes published functional neuroimaging studies of predictors of medication or psychotherapy outcome in major depressive disorder, obsessive-compulsive disorder (OCD), posttraumatic stress disorder, generalized anxiety disorder, panic disorder, and social anxiety disorder. In major depressive disorder and OCD, there is converging evidence of specific brain circuitry that has both been implicated in the disordered state itself, and where pretreatment activation levels have been predictive of treatment response. Specifically, in major depressive disorder, greater pretreatment ventral and pregenual anterior cingulate cortex (ACC) activation may predict better antidepressant medication outcome but poorer psychotherapy outcome. In OCD, activation in the ACC and orbitofrontal cortex has been inversely associated with pharmacological treatment response. In other anxiety disorders, research in this area is just beginning, with the ACC potentially implicated. However, the question of whether these results can directly translate to clinical practice remains open. In order to achieve the goal of single patient level prediction and individualized treatment, future research should strive to establish replicable models with good predictive performance and clear incremental validity.

    View details for DOI 10.1002/da.22299

    View details for PubMedID 25407582

  • Single-Subject Anxiety Treatment Outcome Prediction using Functional Neuroimaging NEUROPSYCHOPHARMACOLOGY Ball, T. M., Stein, M. B., Ramsawh, H. J., Campbell-Sills, L., Paulus, M. P. 2014; 39 (5): 1254–61


    The possibility of individualized treatment prediction has profound implications for the development of personalized interventions for patients with anxiety disorders. Here we utilize random forest classification and pre-treatment functional magnetic resonance imaging (fMRI) data from individuals with generalized anxiety disorder (GAD) and panic disorder (PD) to generate individual subject treatment outcome predictions. Before cognitive behavioral therapy (CBT), 48 adults (25 GAD and 23 PD) reduced (via cognitive reappraisal) or maintained their emotional responses to negative images during fMRI scanning. CBT responder status was predicted using activations from 70 anatomically defined regions. The final random forest model included 10 predictors contributing most to classification accuracy. A similar analysis was conducted using the clinical and demographic variables. Activations in the hippocampus during maintenance and anterior insula, superior temporal, supramarginal, and superior frontal gyri during reappraisal were among the best predictors, with greater activation in responders than non-responders. The final fMRI-based model yielded 79% accuracy, with good sensitivity (0.86), specificity (0.68), and positive and negative likelihood ratios (2.73, 0.20). Clinical and demographic variables yielded poorer accuracy (69%), sensitivity (0.79), specificity (0.53), and likelihood ratios (1.67, 0.39). This is the first use of random forest models to predict treatment outcome from pre-treatment neuroimaging data in psychiatry. Together, random forest models and fMRI can provide single-subject predictions with good test characteristics. Moreover, activation patterns are consistent with the notion that greater activation in cortico-limbic circuitry predicts better CBT response in GAD and PD.

    View details for PubMedID 24270731

    View details for PubMedCentralID PMC3957121

  • Prefrontal dysfunction during emotion regulation in generalized anxiety and panic disorders PSYCHOLOGICAL MEDICINE Ball, T. M., Ramsawh, H. J., Campbell-Sills, L., Paulus, M. P., Stein, M. B. 2013; 43 (7): 1475-1486


    The mechanisms that contribute to emotion dysregulation in anxiety disorders are not well understood. Two common disorders, generalized anxiety disorder (GAD) and panic disorder (PD), were examined to test the hypothesis that both disorders are characterized by hypo-activation in prefrontal cortex (PFC) during emotion regulation. A competing hypothesis that GAD in particular is characterized by PFC hyper-activation during emotion regulation (reflecting overactive top-down control) was also evaluated. Method Twenty-two medication-free healthy control (HC), 23 GAD, and 18 PD participants underwent functional magnetic resonance imaging (fMRI) during a task that required them to reappraise (i.e. reduce) or maintain emotional responses to negative images.GAD participants reported the least reappraisal use in daily life, and reappraisal use was inversely associated with anxiety severity and functional impairment in these participants. During fMRI, HCs demonstrated greater activation during both reappraisal and maintenance than either GAD or PD participants (who did not differ) in brain areas important for emotion regulation (e.g. dorsolateral and dorsomedial PFC). Furthermore, across all anxious participants, activation during reappraisal in dorsolateral and dorsomedial PFC was inversely associated with anxiety severity and functional impairment.Emotion dysregulation in GAD and PD may be the consequence of PFC hypo-activation during emotion regulation, consistent with insufficient top-down control. The relationship between PFC hypo-activation and functional impairment suggests that the failure to engage PFC during emotion regulation may be part of the critical transition from dispositionally high anxiety to an anxiety disorder.

    View details for DOI 10.1017/S0033291712002383

    View details for Web of Science ID 000320449300013

    View details for PubMedID 23111120

    View details for PubMedCentralID PMC4308620

  • Selective effects of social anxiety, anxiety sensitivity, and negative affectivity on the neural bases of emotional face processing NEUROIMAGE Ball, T. M., Sullivan, S., Flagan, T., Hitchcock, C. A., Simmons, A., Paulus, M. P., Stein, M. B. 2012; 59 (2): 1879-1887


    Individuals with high anxiety show heightened neural activation in affective processing regions, including the amygdala and insula. Activations have been shown to be correlated with anxiety severity, but although anxiety is a heterogeneous state, prior studies have not systematically disentangled whether neural activity in affective processing circuitry is uniquely related to specific domains of anxiety. Forty-five young adults were tested on an emotional face processing task during functional magnetic resonance imaging. Participants completed the Social Interactional Anxiety Scale, Anxiety Sensitivity Index, and Spielberger Trait Anxiety Inventory. Using a robust multiple regression approach, we examined the effects of social anxiety, anxiety sensitivity, and trait anxiety (which overlapped with depressive symptoms, and can therefore be considered a measure of negative affectivity) on activation in insula, amygdala, and medial prefrontal cortex, in response to emotional faces. Adjusting for negative affectivity and anxiety sensitivity, social anxiety was associated with activity in left amygdala, right insula, and subgenual anterior cingulate across all emotional faces. When comparing negative and positive faces directly, greater negative affectivity was uniquely associated with less activity to positive faces in left amygdala, left anterior insula, and dorsal anterior cingulate. The current findings support the hypothesis that hyperactivity in brain areas during general emotional face processing is predominantly a function of social anxiety. In comparison, hypoactivity to positively valenced faces was predominantly associated with negative affectivity. Implications for the understanding of emotion processing in anxiety are discussed.

    View details for DOI 10.1016/j.neuroimage.2011.08.074

    View details for PubMedID 21920442

  • Assessing Emotion Regulation in Social Anxiety Disorder: The Emotion Regulation Interview JOURNAL OF PSYCHOPATHOLOGY AND BEHAVIORAL ASSESSMENT Werner, K. H., Goldin, P. R., Ball, T. M., Heimberg, R. G., Gross, J. J. 2011; 33 (3): 346-354
  • Neural Mechanisms of Cognitive Reappraisal of Negative Self-Beliefs in Social Anxiety Disorder BIOLOGICAL PSYCHIATRY Goldin, P. R., Manber-Ball, T., Werner, K., Heimberg, R., Gross, J. J. 2009; 66 (12): 1091-1099


    Social anxiety disorder (SAD) is characterized by distorted negative self-beliefs (NSBs), which are thought to enhance emotional reactivity, interfere with emotion regulation, and undermine social functioning. Cognitive reappraisal is a type of emotion regulation used to alter NSBs, with the goal of modulating emotional reactivity. Despite its relevance, little is known about the neural bases and temporal features of cognitive reappraisal in patients with SAD.Twenty-seven patients with SAD and 27 healthy control subjects (HCs) were trained to react and to implement cognitive reappraisal to downregulate negative emotional reactivity to NSBs, while undergoing functional magnetic resonance imaging and providing ratings of negative emotion experience.Behaviorally, compared with HCs, patients with SAD reported greater negative emotion both while reacting to and reappraising NSBs. However, when cued, participants in both groups were able to use cognitive reappraisal to decrease negative emotion. Neurally, reacting to NSBs resulted in early amygdala response in both groups. Reappraising NSBs resulted in greater early cognitive control, language, and visual processing in HCs but greater late cognitive control, visceral, and visual processing in patients with SAD. Functional connectivity analysis during reappraisal identified more regulatory regions inversely related to left amygdala in HCs than in patients with SAD. Reappraisal-related brain regions that differentiated patients and control subjects were associated with negative emotion ratings and cognitive reappraisal self-efficacy.Findings regarding cognitive reappraisal suggest neural timing, connectivity, and brain-behavioral associations specific to patients with SAD and elucidate neural mechanisms that might serve as biomarkers of interventions for SAD.

    View details for DOI 10.1016/j.biopsych.2009.07.014

    View details for Web of Science ID 000272599500004

    View details for PubMedID 19717138

    View details for PubMedCentralID PMC2788040